Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Dabigatran Etexilate Market Report 2016

  • QYR704236
  • 122 Pages
  • October 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Dabigatran Etexilate

Revenue, means the sales value of Dabigatran Etexilate

This report studies sales (consumption) of Dabigatran Etexilate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Pfizer, Inc. (US)

Bayer Healthcare AG (Germany)

GlaxoSmithKline Plc. (UK)

Boehringer Ingelheim (Germany)

Sanofi S.A. (France)

Abbott India Limited (India)

Aspen Holdings (South Africa)

Bristol-Myers Squibb Company (US)

Eisai Inc. (US)

Mitsubishi Tanabe Pharma Corporation (Japan)

Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Dabigatran Etexilate in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Dabigatran Etexilate Market Report 2016

1 Dabigatran Etexilate Overview

1.1 Product Overview and Scope of Dabigatran Etexilate

1.2 Classification of Dabigatran Etexilate

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Dabigatran Etexilate

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Dabigatran Etexilate (2011-2021)

1.4.1 United States Dabigatran Etexilate Sales and Growth Rate (2011-2021)

1.4.2 United States Dabigatran Etexilate Revenue and Growth Rate (2011-2021)

2 United States Dabigatran Etexilate Competition by Manufacturers

2.1 United States Dabigatran Etexilate Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Dabigatran Etexilate Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Dabigatran Etexilate Average Price by Manufactures (2015 and 2016)

2.4 Dabigatran Etexilate Market Competitive Situation and Trends

2.4.1 Dabigatran Etexilate Market Concentration Rate

2.4.2 Dabigatran Etexilate Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Dabigatran Etexilate Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Dabigatran Etexilate Sales and Market Share by Type (2011-2016)

3.2 United States Dabigatran Etexilate Revenue and Market Share by Type (2011-2016)

3.3 United States Dabigatran Etexilate Price by Type (2011-2016)

3.4 United States Dabigatran Etexilate Sales Growth Rate by Type (2011-2016)

4 United States Dabigatran Etexilate Sales (Volume) by Application (2011-2016)

4.1 United States Dabigatran Etexilate Sales and Market Share by Application (2011-2016)

4.2 United States Dabigatran Etexilate Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Dabigatran Etexilate Manufacturers Profiles/Analysis

5.1 Pfizer, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Dabigatran Etexilate Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer, Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Bayer Healthcare AG (Germany)

5.2.2 Dabigatran Etexilate Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Bayer Healthcare AG (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 GlaxoSmithKline Plc. (UK)

5.3.2 Dabigatran Etexilate Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 GlaxoSmithKline Plc. (UK) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Boehringer Ingelheim (Germany)

5.4.2 Dabigatran Etexilate Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Boehringer Ingelheim (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Sanofi S.A. (France)

5.5.2 Dabigatran Etexilate Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Sanofi S.A. (France) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Abbott India Limited (India)

5.6.2 Dabigatran Etexilate Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Abbott India Limited (India) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Aspen Holdings (South Africa)

5.7.2 Dabigatran Etexilate Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Aspen Holdings (South Africa) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bristol-Myers Squibb Company (US)

5.8.2 Dabigatran Etexilate Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bristol-Myers Squibb Company (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Eisai Inc. (US)

5.9.2 Dabigatran Etexilate Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Eisai Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Mitsubishi Tanabe Pharma Corporation (Japan)

5.10.2 Dabigatran Etexilate Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 Dabigatran Etexilate Manufacturing Cost Analysis

6.1 Dabigatran Etexilate Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Dabigatran Etexilate

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Dabigatran Etexilate Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Dabigatran Etexilate Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Dabigatran Etexilate Market Forecast (2016-2021)

10.1 United States Dabigatran Etexilate Sales, Revenue Forecast (2016-2021)

10.2 United States Dabigatran Etexilate Sales Forecast by Type (2016-2021)

10.3 United States Dabigatran Etexilate Sales Forecast by Application (2016-2021)

10.4 Dabigatran Etexilate Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Dabigatran Etexilate

Table Classification of Dabigatran Etexilate

Figure United States Sales Market Share of Dabigatran Etexilate by Type in 2015

Table Application of Dabigatran Etexilate

Figure United States Sales Market Share of Dabigatran Etexilate by Application in 2015

Figure United States Dabigatran Etexilate Sales and Growth Rate (2011-2021)

Figure United States Dabigatran Etexilate Revenue and Growth Rate (2011-2021)

Table United States Dabigatran Etexilate Sales of Key Manufacturers (2015 and 2016)

Table United States Dabigatran Etexilate Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Dabigatran Etexilate Sales Share by Manufacturers

Figure 2016 Dabigatran Etexilate Sales Share by Manufacturers

Table United States Dabigatran Etexilate Revenue by Manufacturers (2015 and 2016)

Table United States Dabigatran Etexilate Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Dabigatran Etexilate Revenue Share by Manufacturers

Table 2016 United States Dabigatran Etexilate Revenue Share by Manufacturers

Table United States Market Dabigatran Etexilate Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Dabigatran Etexilate Average Price of Key Manufacturers in 2015

Figure Dabigatran Etexilate Market Share of Top 3 Manufacturers

Figure Dabigatran Etexilate Market Share of Top 5 Manufacturers

Table United States Dabigatran Etexilate Sales by Type (2011-2016)

Table United States Dabigatran Etexilate Sales Share by Type (2011-2016)

Figure United States Dabigatran Etexilate Sales Market Share by Type in 2015

Table United States Dabigatran Etexilate Revenue and Market Share by Type (2011-2016)

Table United States Dabigatran Etexilate Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Dabigatran Etexilate by Type (2011-2016)

Table United States Dabigatran Etexilate Price by Type (2011-2016)

Figure United States Dabigatran Etexilate Sales Growth Rate by Type (2011-2016)

Table United States Dabigatran Etexilate Sales by Application (2011-2016)

Table United States Dabigatran Etexilate Sales Market Share by Application (2011-2016)

Figure United States Dabigatran Etexilate Sales Market Share by Application in 2015

Table United States Dabigatran Etexilate Sales Growth Rate by Application (2011-2016)

Figure United States Dabigatran Etexilate Sales Growth Rate by Application (2011-2016)

Table Pfizer, Inc. (US) Basic Information List

Table Pfizer, Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Bayer Healthcare AG (Germany) Basic Information List

Table Bayer Healthcare AG (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Healthcare AG (Germany) Dabigatran Etexilate Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc. (UK) Basic Information List

Table GlaxoSmithKline Plc. (UK) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc. (UK) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Boehringer Ingelheim (Germany) Basic Information List

Table Boehringer Ingelheim (Germany) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim (Germany) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Sanofi S.A. (France) Basic Information List

Table Sanofi S.A. (France) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A. (France) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Abbott India Limited (India) Basic Information List

Table Abbott India Limited (India) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott India Limited (India) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Aspen Holdings (South Africa) Basic Information List

Table Aspen Holdings (South Africa) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Aspen Holdings (South Africa) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Company (US) Basic Information List

Table Bristol-Myers Squibb Company (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Company (US) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Eisai Inc. (US) Basic Information List

Table Eisai Inc. (US) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai Inc. (US) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List

Table Mitsubishi Tanabe Pharma Corporation (Japan) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mitsubishi Tanabe Pharma Corporation (Japan) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List

Table Teva Pharmaceutical Industries Ltd. (Israel) Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Pharmaceutical Industries Ltd. (Israel) Dabigatran Etexilate Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Dabigatran Etexilate

Figure Manufacturing Process Analysis of Dabigatran Etexilate

Figure Dabigatran Etexilate Industrial Chain Analysis

Table Raw Materials Sources of Dabigatran Etexilate Major Manufacturers in 2015

Table Major Buyers of Dabigatran Etexilate

Table Distributors/Traders List

Figure United States Dabigatran Etexilate Production and Growth Rate Forecast (2016-2021)

Figure United States Dabigatran Etexilate Revenue and Growth Rate Forecast (2016-2021)

Table United States Dabigatran Etexilate Production Forecast by Type (2016-2021)

Table United States Dabigatran Etexilate Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370